3,5-diiodothyropropionic acid

DB12629InvestigationalSmall molecule

DITPA has been investigated in Congestive Heart Failure.

Chemical structure of 3,5-diiodothyropropionic acid
Mechanism
Curator reviewed
Formula / weight
C15H12I2O4 · 510.066 g/mol (avg)
Also known as
DITPA

Resolves to

Compound
UNII1HTO2X0SJ9CAS1158-10-7ChEMBLCHEMBL2348292ChEBI134267PubChem160565
Structure
InChIKeyWONYMNWUJVKVII-UHFFFAOYSA-NSMILESOC(=O)CCC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
317Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of 3,5-diiodothyropropionic acid, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In